Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population - PubMed (original) (raw)
Clinical Trial
. 1993 Sep 15;85(18):1483-92.
doi: 10.1093/jnci/85.18.1483.
Affiliations
- PMID: 8360931
- DOI: 10.1093/jnci/85.18.1483
Clinical Trial
Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population
W J Blot et al. J Natl Cancer Inst. 1993.
Abstract
Background: Epidemiologic evidence indicates that diets high in fruits and vegetables are associated with a reduced risk of several cancers, including cancers of the esophagus and stomach. Vitamins and minerals in these foods may contribute to the reduced cancer risk. The people of Linxian County, China, have one of the world's highest rates of esophageal/gastric cardia cancer and a persistently low intake of several micronutrients.
Purpose: We sought to determine if dietary supplementation with specific vitamins and minerals can lower mortality from or incidence of cancer as well as mortality from other diseases in Linxian.
Methods: Individuals of ages 40-69 were recruited in 1985 from four Linxian communes. Mortality and cancer incidence during March 1986-May 1991 were ascertained for 29,584 adults who received daily vitamin and mineral supplementation throughout this period. The subjects were randomly assigned to intervention groups according to a one-half replicate of a 2(4) factorial experimental design. This design enabled testing for the effects of four combinations of nutrients: (A) retinol and zinc; (B) riboflavin and niacin; (C) vitamin C and molybdenum; and (D) beta carotene, vitamin E, and selenium. Doses ranged from one to two times U.S. Recommended Daily Allowances.
Results: A total of 2127 deaths occurred among trial participants during the intervention period. Cancer was the leading cause of death, with 32% of all deaths due to esophageal or stomach cancer, followed by cerebrovascular disease (25%). Significantly (P = .03) lower total mortality (relative risk [RR] = 0.91; 95% confidence interval [CI] = 0.84-0.99) occurred among those receiving supplementation with beta carotene, vitamin E, and selenium. The reduction was mainly due to lower cancer rates (RR = 0.87; 95% CI = 0.75-1.00), especially stomach cancer (RR = 0.79; 95% CI = 0.64-0.99), with the reduced risk beginning to arise about 1-2 years after the start of supplementation with these vitamins and minerals. No significant effects on mortality rates from all causes were found for supplementation with retinol and zinc, riboflavin and niacin, or vitamin C and molybdenum. Patterns of cancer incidence, on the basis of 1298 cases, generally resembled those for cancer mortality.
Conclusions: The findings indicate that vitamin and mineral supplementation of the diet of Linxian adults, particularly with the combination of beta carotene, vitamin E, and selenium, may effect a reduction in cancer risk in this population.
Implications: The results on their own are not definitive, but the promising findings should stimulate further research to clarify the potential benefits of micronutrient supplements.
Comment in
- Re: Health claims about vitamin C and cancer.
Ziegler RG, Byers T. Ziegler RG, et al. J Natl Cancer Inst. 1994 Jun 1;86(11):871-2. doi: 10.1093/jnci/86.11.871-a. J Natl Cancer Inst. 1994. PMID: 8182771 No abstract available. - Clinical chemoprevention: developing a cancer prevention strategy.
Benner SE, Hong WK. Benner SE, et al. J Natl Cancer Inst. 1993 Sep 15;85(18):1446-7. doi: 10.1093/jnci/85.18.1446. J Natl Cancer Inst. 1993. PMID: 8360923 No abstract available. - Dietary supplements reduce cancer deaths in China.
Smigel K. Smigel K. J Natl Cancer Inst. 1993 Sep 15;85(18):1448-50. doi: 10.1093/jnci/85.18.1448. J Natl Cancer Inst. 1993. PMID: 8360924 No abstract available.
Similar articles
- Nutrition intervention trials in Linxian, China: multiple vitamin/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia.
Li JY, Taylor PR, Li B, Dawsey S, Wang GQ, Ershow AG, Guo W, Liu SF, Yang CS, Shen Q, et al. Li JY, et al. J Natl Cancer Inst. 1993 Sep 15;85(18):1492-8. doi: 10.1093/jnci/85.18.1492. J Natl Cancer Inst. 1993. PMID: 8360932 Clinical Trial. - Prevention of esophageal cancer: the nutrition intervention trials in Linxian, China. Linxian Nutrition Intervention Trials Study Group.
Taylor PR, Li B, Dawsey SM, Li JY, Yang CS, Guo W, Blot WJ. Taylor PR, et al. Cancer Res. 1994 Apr 1;54(7 Suppl):2029s-2031s. Cancer Res. 1994. PMID: 8137333 Clinical Trial. - Effects of vitamin/mineral supplementation on the prevalence of histological dysplasia and early cancer of the esophagus and stomach: results from the General Population Trial in Linxian, China.
Wang GQ, Dawsey SM, Li JY, Taylor PR, Li B, Blot WJ, Weinstein WM, Liu FS, Lewin KJ, Wang H, et al. Wang GQ, et al. Cancer Epidemiol Biomarkers Prev. 1994 Mar;3(2):161-6. Cancer Epidemiol Biomarkers Prev. 1994. PMID: 8049638 Clinical Trial. - Micronutrient supplementation trials and the reduction of cancer and cerebrovascular incidence and mortality.
Mobarhan S. Mobarhan S. Nutr Rev. 1994 Mar;52(3):102-5. doi: 10.1111/j.1753-4887.1994.tb01399.x. Nutr Rev. 1994. PMID: 8015747 Review. - Vitamin/mineral supplementation and cancer risk: international chemoprevention trials.
Blot WJ. Blot WJ. Proc Soc Exp Biol Med. 1997 Nov;216(2):291-6. doi: 10.3181/00379727-216-44180. Proc Soc Exp Biol Med. 1997. PMID: 9349699 Review.
Cited by
- Scientific opinion on the tolerable upper intake level for preformed vitamin A and β-carotene.
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA); Turck D, Bohn T, Castenmiller J, de Henauw S, Hirsch-Ernst KI, Knutsen HK, Maciuk A, Mangelsdorf I, McArdle HJ, Pentieva K, Siani A, Thies F, Tsabouri S, Vinceti M, Lietz G, Passeri G, Craciun I, Fabiani L, Horvath Z, Valtueña Martínez S, Naska A. EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), et al. EFSA J. 2024 Jun 6;22(6):e8814. doi: 10.2903/j.efsa.2024.8814. eCollection 2024 Jun. EFSA J. 2024. PMID: 38846679 Free PMC article. - Mini-encyclopedia of mitochondria-relevant nutraceuticals protecting health in primary and secondary care-clinically relevant 3PM innovation.
Golubnitschaja O, Kapinova A, Sargheini N, Bojkova B, Kapalla M, Heinrich L, Gkika E, Kubatka P. Golubnitschaja O, et al. EPMA J. 2024 Apr 18;15(2):163-205. doi: 10.1007/s13167-024-00358-4. eCollection 2024 Jun. EPMA J. 2024. PMID: 38841620 Free PMC article. - Effects of primary or secondary prevention with vitamin A supplementation on clinically important outcomes: a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis.
Bjelakovic G, Nikolova D, Bjelakovic M, Pavlov CS, Sethi NJ, Korang SK, Gluud C. Bjelakovic G, et al. BMJ Open. 2024 May 30;14(5):e078053. doi: 10.1136/bmjopen-2023-078053. BMJ Open. 2024. PMID: 38816049 Free PMC article. - Insights into the Management of Chronic Hepatitis in Children-From Oxidative Stress to Antioxidant Therapy.
Ioniuc I, Lupu A, Tarnita I, Mastaleru A, Trandafir LM, Lupu VV, Starcea IM, Alecsa M, Morariu ID, Salaru DL, Azoicai A. Ioniuc I, et al. Int J Mol Sci. 2024 Mar 31;25(7):3908. doi: 10.3390/ijms25073908. Int J Mol Sci. 2024. PMID: 38612717 Free PMC article. Review. - Diet Quality and Subsequent Incidence of Upper Gastrointestinal Cancers: Results from the Golestan Cohort Study.
Namaki M, Hashemian M, Arj A, Poustchi H, Roshandel G, Loghman AH, Sepanlou SG, Pourshams A, Khoshnia M, Gharavi A, Abdolahi N, Besharat S, Hekmatdoost A, Brennan P, Dawsey SM, Kamangar F, Boffetta P, Abnet CC, Malekzadeh R, Sheikh M. Namaki M, et al. Arch Iran Med. 2023 Sep 1;26(9):489-498. doi: 10.34172/aim.2023.74. Arch Iran Med. 2023. PMID: 38310404 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources